|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Write-off of inventory and change in inventory reserve | |||||
| Adjustment to property and equipment for sales type leases | |||||
| Loss on impairment of property and equipment | |||||
| Loss on impairment of intangible asset | |||||
| Loss on disposal of property and equipment | |||||
| Stock-based compensation | |||||
| Non-cash interest expense | |||||
| (Accretion) amortization of (discount) premium on marketable securities, net of change in accrued interest | |||||
| Provision recorded for allowance for doubtful accounts | |||||
| Non-cash lease expense | |||||
| Change in allowance for expected credit losses | |||||
| Loss on extinguishment of debt | |||||
| Change in fair value of earn-out liability | |||||
| Change in fair value of contingently issuable common stock | |||||
| Change in fair value of contingently issuable/returnable common stock liability/asset | |||||
| Change in fair value of public warrant liability | |||||
| Changes in operating assets and liabilities | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Commission assets | |||||
| Contract assets | |||||
| Other assets | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Deferred revenue | |||||
| Accrued expenses and other current liabilities | |||||
| Operating lease liability | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Development of internal-use software | |||||
| Purchases of property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Purchases of marketable securities | |||||
| Proceeds from maturities of marketable securities | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from long-term debt | |||||
| Repayment of principal on long-term debt | |||||
| Payment of debt issuance costs and prepayment penalty | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosure of cash flow information | |||||
| Cash paid for interest | |||||
| Supplemental disclosure of non-cash activities | |||||
| Transfer of property and equipment to inventory | |||||
| Capital expenditures incurred but not yet paid | |||||
| Capitalization of stock compensation | |||||
| Finback exercise price | |||||
| Operating lease liabilities arising from obtaining right-of-use assets | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
| Restricted cash, noncurrent | |||||
| Conversion of contingently issuable common stock | |||||
Loading...